Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

por Lange, Claudia, Tetzner, Reimo, Strunz, Tobias, Rittenhouse, Kay D.
Publicado 2023

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

por Lange, Claudia, Tetzner, Reimo, Strunz, Tobias, Rittenhouse, Kay D.
Publicado 2023

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

por Eissing, Thomas, Stewart, Michael W., Qian, Cynthia X., Rittenhouse, Kay D.
Publicado 2021

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model

por Schubert, William, Terjung, Carsten, Rafique, Ashique, Romano, Carmelo, Ellinger, Philipp, Rittenhouse, Kay D.
Publicado 2022

VEGFR1 signaling in retinal angiogenesis and microinflammation

por Uemura, Akiyoshi, Fruttiger, Marcus, D’Amore, Patricia A., De Falco, Sandro, Joussen, Antonia M., Sennlaub, Florian, Brunck, Lynne R., Johnson, Kristian T., Lambrou, George N., Rittenhouse, Kay D., Langmann, Thomas
Publicado 2021

Integrated results from the COPERNICUS and GALILEO studies

por Pielen, Amelie, Clark, W Lloyd, Boyer, David S, Ogura, Yuichiro, Holz, Frank G, Korobelnik, Jean-Francois, Stemper, Brigitte, Asmus, Friedrich, Rittenhouse, Kay D, Ahlers, Christiane, Vitti, Robert, Saroj, Namrata, Zeitz, Oliver, Haller, Julia A
Publicado 2017